Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Day High:
Day Low:
Copyright West LLC. Minimum 15 minutes delayed.

Investor Relations

Press Releases

May 10, 2023

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

April 26, 2023

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

February 28, 2023

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023

Events and Presentations

Upcoming Events
More events are coming soon.




Stock Quote & Analyst Coverage

Stock Quote ()

Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
Vericel Corporation is covered by the following analysts.
Ryan Zimmerman
Swayampakula Ramakanth
H.C. Wainwright & Co.
Jeff Cohen
Ladenburg Thalmann
George Sellers
Samuel Brodovsky

Vericel Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Vericel Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vericel Corporation or its management. Vericel Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.